Prognostic factors in Acanthamoeba keratitis

Canadian Journal of Ophthalmology

Volumn 47, Issue 3, 2012, Pages 312-317

  Kaiserman, Igor ^a   Bahar, Irit ^a   McAllum, Penny ^a   Srinivasan, Sathish ^a   Elbaz, Uri ^a   Slomovic, Allan R ^a   Rootman, David S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; GRAMICIDIN D; NEOMYCIN; NEOSPORIN; POLYMYXIN B; PROPAMIDINE ISETHIONATE;

ACANTHAMOEBA KERATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTACT LENS; CONTROLLED STUDY; DENDRITE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIVARIATE ANALYSIS; NEURITIS; PROGNOSIS; REGRESSION ANALYSIS; SKIN DEFECT; SPECTACLES; VISUAL ACUITY;

EID: 84862280054     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/j.jcjo.2012.03.040     Document Type: Article

References (24)

1. Bacon AS, Frazer DG, Dart JK, et al. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye. 1993;7:719-25. (Pubitemid 24013278)
2. Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD. Amoebic infection of the eye. Lancet. 1974;2:1537-40.
3. Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea. 1998;17:3-10. (Pubitemid 28047002)
4. Lam DS, Houang E, Fan DS, et al. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye (London, England). 2002;16:608-18.
5. Seal DV, Beattie TK, Tomlinson A, Fan D, Wong E. Acanthamoeba keratitis. Br J Ophthalmol. 2003;87:516-7.
6. Stevenson RW, Seal DV. Has the introduction of multi-purpose solutions contributed to a reduced incidence of Acanthamoeba keratitis in contact lens wearers? A review. Cont Lens Anterior Eye. 1998;21:89-92. (Pubitemid 128535744)
7. Joslin CE, Tu EY, McMahon TT, Passaro DJ, Stayner LT, Sugar J. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol. 2006;142:212-7.
8. Patel A, Hammersmith K. Contact lens-related microbial keratitis: recent outbreaks. Curr Opin Ophthalmol. 2008;19:302-6.
9. Yu DK, Ng AS, Lau WW, Wong CC, Chan CW. Recent pattern of contact lens-related keratitis in Hong Kong. Eye Contact Lens. 2007;33: 284-7. (Pubitemid 350098713)
10. McAllum P, Bahar I, Kaiserman I, Srinivasan S, Slomovic A, Rootman D. Temporal and seasonal trends in Acanthamoeba keratitis. Cornea. 2009;28:7-10.
11. Auran JD, Starr MB, Jakobiec FA. Acanthamoeba keratitis. A review of the literature. Cornea. 1987;6:2-26.
12. Chynn EW, Lopez MA, Pavan-Langston D, Talamo JH. Acanthamoeba keratitis. Contact lens and noncontact lens characteristics. Ophthalmology. 1995;102:1369-73.
13. Tu EY, Joslin CE, Sugar J, Shoff ME, Booton GC. Prognostic factors affecting visual outcome in Acanthamoeba keratitis. Ophthalmology. 2008;115:1998-2003.
14. Butler TK, Males JJ, Robinson LP, et al. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002. Clin Experiment Ophthalmol. 2005;33:41-6. (Pubitemid 40330974)
15. Duguid IG, Dart JK, Morlet N, et al. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology. 1997;104:1587-92. (Pubitemid 28053455)
16. Kilvington S, Gray T, Dart J, et al. Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom. Invest Ophthalmol Vis Sci. 2004;45:165-9. (Pubitemid 38055683)
17. Moore MB, McCulley JP, Kaufman HE, Robin JB. Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis. Ophthalmology. 1986;93:1310-5. (Pubitemid 16008995)
18. Seal D. Treatment of Acanthamoeba keratitis. Expert Rev Anti Infect Ther. 2003;1:205-8. (Pubitemid 38855083)
19. Claerhout I, Goegebuer A, Van Den Broecke C, Kestelyn P. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol. 2004;242:648-53. (Pubitemid 39242839)
20. Seal D, Hay J, Kirkness C, et al. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye. 1996;10:413-21. (Pubitemid 26285546)
21. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye. 1994;8:555-63. (Pubitemid 24331500)
22. Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye (London, England). 2003;17: 893-905. (Pubitemid 37541042)
23. Mathers W. Use of higher medication concentrations in the treatment of Acanthamoeba keratitis. Arch Ophthalmol. 2006;124:923. (Pubitemid 43877698)
24. Park DH, Palay DA, Daya SM, Stulting RD, Krachmer JH, Holland EJ. The role of topical corticosteroids in the management of Acanthamoeba keratitis. Cornea. 1997;16:277-83. (Pubitemid 27190793)